Lexaria Bioscience (LEXX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lexaria Bioscience has announced a $5 million registered direct offering, pricing its shares at-the-market under Nasdaq rules. The company will also issue unregistered warrants for additional shares, with proceeds intended for working capital and corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.